Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation

doi:10.12998/wjcc.v10.i27.9588

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3457)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

144

WORD

HTML

1904

Figures (1-4)

515

Tables (1-1)

270

Sum=2881

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

201

Download

375

Sum=576

Sep 26, 2022 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Sep 26, 2022; 10(27): 9588-9601
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9588

Full Size Figure Download Figure

Figure 2 Reprogramming of human somatic cells, such as fibroblasts, into human induced pluripotent stem cells is compared with the inner cell mass of embryonic stem cells.

Citation: Leowattana W, Leowattana T, Leowattana P. Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation. World J Clin Cases 2022; 10(27): 9588-9601
URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9588.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i27.9588